Smithfield Trust’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $93K | Sell |
470
-244
| -34% | -$50.6K | ﹤0.01% | 511 |
|
|
2026
Q1 | $159K | Buy |
714
+10
| +1% | +$2.49K | 0.01% | 405 |
|
|
2025
Q4 | $169K | Sell |
704
-400
| -36% | -$102K | 0.01% | 385 |
|
|
2025
Q3 | $303K | Buy |
1,104
+400
| +57% | +$109K | 0.01% | 290 |
|
|
2025
Q2 | $182K | Sell |
704
-16
| -2% | -$3.82K | 0.01% | 353 |
|
|
2025
Q1 | $161K | Buy |
720
+16
| +2% | +$3.73K | 0.01% | 376 |
|
|
2024
Q4 | $160K | Buy |
704
+200
| +40% | +$48.2K | 0.01% | 378 |
|
|
2024
Q3 | $124K | Buy |
504
+38
| +8% | +$8.49K | 0.01% | 421 |
|
|
2024
Q2 | $89K | Buy |
466
+196
| +73% | +$39.8K | ﹤0.01% | 459 |
|
|
2024
Q1 | $54K | Hold |
270
| – | – | ﹤0.01% | 553 |
|
|
2023
Q4 | $46K | Sell |
270
-2
| -0.7% | -$307 | ﹤0.01% | 566 |
|
|
2023
Q3 | $40K | Buy |
272
+2
| +0.7% | +$362 | ﹤0.01% | 566 |
|
|
2023
Q2 | $58K | Hold |
270
| – | – | ﹤0.01% | 530 |
|
|
2023
Q1 | $59K | Hold |
270
| – | – | ﹤0.01% | 501 |
|
|
2022
Q4 | $56K | Hold |
270
| – | – | ﹤0.01% | 501 |
|
|
2022
Q3 | $58K | Hold |
270
| – | – | ﹤0.01% | 481 |
|
|
2022
Q2 | $57K | Hold |
270
| – | – | ﹤0.01% | 517 |
|
|
2022
Q1 | $65K | Hold |
270
| – | – | ﹤0.01% | 519 |
|
|
2021
Q4 | $70K | Hold |
270
| – | – | ﹤0.01% | 513 |
|
|
2021
Q3 | $71K | Hold |
270
| – | – | ﹤0.01% | 507 |
|
|
2021
Q2 | $67K | Hold |
270
| – | – | ﹤0.01% | 508 |
|
|
2021
Q1 | $52K | Hold |
270
| – | – | ﹤0.01% | 548 |
|
|
2020
Q4 | $57K | Hold |
270
| – | – | ﹤0.01% | 503 |
|
|
2020
Q3 | $46K | Buy |
270
+170
| +170% | +$31.4K | ﹤0.01% | 520 |
|
|
2020
Q2 | $19K | Hold |
100
| – | – | ﹤0.01% | 632 |
|
|
2020
Q1 | $15K | Sell |
100
-1,378
| -93% | -$219K | ﹤0.01% | 625 |
|
|
2019
Q4 | $229K | Buy |
1,478
+216
| +17% | +$31.1K | 0.02% | 259 |
|
|
2019
Q3 | $171K | Buy |
1,262
+222
| +21% | +$29.1K | 0.02% | 291 |
|
|
2019
Q2 | $127K | Buy |
1,040
+940
| +940% | +$104K | 0.01% | 352 |
|
|
2019
Q1 | $10K | Hold |
100
| – | – | ﹤0.01% | 678 |
|
|
2018
Q4 | $11K | Hold |
100
| – | – | ﹤0.01% | 652 |
|
|
2018
Q3 | $12K | Hold |
100
| – | – | ﹤0.01% | 704 |
|
|
2018
Q2 | $10K | Hold |
100
| – | – | ﹤0.01% | 740 |
|
|
2018
Q1 | $10K | Hold |
100
| – | – | ﹤0.01% | 730 |
|
|
2017
Q4 | $8K | Buy |
+100
| New | +$8.26K | ﹤0.01% | 791 |
|
|
2016
Q4 | – | Sell |
-83
| Closed | -$5K | – | 825 |
|
|
2016
Q3 | $5K | Hold |
83
| – | – | ﹤0.01% | 761 |
|
|
2016
Q2 | $5K | Buy |
+83
| New | +$4.89K | ﹤0.01% | 751 |
|
|
2014
Q1 | – | Sell |
-300
| Closed | -$14K | – | 858 |
|
|
2013
Q4 | $14K | Buy |
+300
| New | +$15.2K | ﹤0.01% | 651 |
|
|
2013
Q3 | – | Sell |
-5,080
| Closed | -$230K | – | 765 |
|
|
2013
Q2 | $230K | Buy |
+5,080
| New | +$241K | 0.06% | 269 |
|
Other funds holding RMD
Smithfield Trust's RMD Position: Q2 2026 in Review
Smithfield Trust reduced its ResMed (RMD) stake by 34% in Q2 2026, selling an estimated $50.6K and leaving 470 shares worth $93K. The position accounts for ﹤0.01% of the portfolio, ranked #511.
Smithfield Trust first reported a position in RMD in Q2 2013 and has held it in 39 quarters since. The position peaked at $303K in Q3 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Smithfield Trust held 470 shares of ResMed worth $93K as of Q2 2026.
- Smithfield Trust sold 244 ResMed shares in Q2 2026, an estimated $50.6K.
- ResMed made up ﹤0.01% of Smithfield Trust's portfolio in Q2 2026, its #511 holding.
- Smithfield Trust first reported a position in ResMed in Q2 2013 and has held it in 39 quarters since.
- Smithfield Trust's ResMed position peaked at $303K in Q3 2025.
- 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Smithfield Trust's 13F filing for Q2 2026, filed 5 Aug 2026.